A decrease in BCAA, as well as an increase in AAA, is associated with advanced liver disease, including hepato-cellular carcinoma (HCC) and is characterized as the BCAA/AAA ratio (Fischer ratio) [35,36]. This evidence concerns the gene ARID4B and hepatocellular carcinoma.